FEATURED ARTICLES
Turning A Historically Limited Modality Into A Respiratory Drug Opportunity
How can sponsors revive a promising modality with known safety limits? Vast Therapeutics CEO Nate Stasko, Ph.D., explains how ALX1 is reshaping nitric oxide delivery.
-
![samples under microscopes, analyze data-GettyImages-2191794159]( "What BriaCell's Trial Design Says About Real-World Cancer Research")
What BriaCell's Trial Design Says About Real-World Cancer ResearchBriaCell President and CEO William Williams, MD, shares how broader eligibility criteria and physician’s choice controls can better reflect real-world cancer care.
-
![Senior consulting with doctor in exam room-GettyImages-2205398583]( "'How Do You Feel?': Designing A Cardiac Trial With A Patient-Reported Primary Endpoint")
'How Do You Feel?': Designing A Cardiac Trial With A Patient-Reported Primary EndpointImbria Pharmaceuticals' Albert Kim, MD, Ph.D., shares why PROs are the point of the company's FORTITUDE-HCM trial for patients with non-obstructive hypertrophic cardiomyopathy.
-
![Medical technology network team meeting-GettyImages-1495785798]( "Building The Execution Architecture For Real-World Data To Have Real-World Impact")
Building The Execution Architecture For Real-World Data To Have Real-World ImpactRWE's next challenge is execution. Learn how life sciences orgns can turn evidence into sustained business and clinical impact.
SERVICES & PRODUCTS
Mobile ophthalmic clinical research and clinical trial on-site support services designed to address challenges across all trial phases and ensure reliable protection of ocular endpoints.
Reach critical first-in-human milestones faster with experienced teams, rapid study start-up, and real-time data that reduce complexity, inform decisions, and de-risk development.
Expert Support for Clinical Research and Research Administration
Proof-of-concept provides a critical bridge between Phase 1 and Phase 2 trials, making an experienced CRO partner vital to achieving optimal outcomes for early-phase clinical research.
Ensure accurate, compliant, and impactful documentation with Altasciences' experienced medical writers and regulatory experts.
Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.